…Background Colorectal cancer (CRC) is a leading cause of cancer-related mortality worldwide.…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsPopular entities in these results
Choose an entity to see the articles in which it was identified.
Matching articles
29,499 articles · page 118 of 2459…nor arm were –41.5% (26.7), –41.8% (23.0) and –32.3% (22.3) for elafibranor in the healthy weight, overweight and obese subgroups respectiv…
…lance guidance highlighting that early treatment of varices and hepatocellular carcinoma (HCC) reduces morbidity and mortality. We hypothesised that the…
…ears of PLA diagnosis, 16 patients (19.28%) developed PLA after CRC diagnosis, and 8 patients (9.64%) developed PLA within 1 year p…
…or disease progression, cirrhosis, and liver-related mortality. Aldafermin, a fibroblast growth factor 19 (FGF19) analog, is one of the ev…
… and assessed their capacity to mediate pathomechanisms.Results Efgartigimod decreased all detectable AChR-specific IgG subclasses. At basel…
…eckpoint inhibitors (ICIs) have revolutionized the treatment of cancer. However, ICIs are associated with potentially life-threatening…
…on in 2020 compare to 2015 (aOR 2.00, 95% CI 1.90 to 2.20), WHO HIV stage II versus stage IV (aOR 2.10, 95% CI 1.90 to 2.30) and ag…
…isks plateauing at around ≥120 min/week of resistance training. Resistance training was associated with further reduced mortality risk at all level…
…and mortality. The management of ICI myocarditis often involves immunosuppressive therapies, as guided by both serum and imaging biomarkers. Elevated level…
…scal Vranckx, Sven Wassmann, Nanette Kass Wenger, Borja Ibanez, ESC Scientific Document Group , 2023 ESC Guidelines for the managem…
… (0.0)1 (100.0)0.083Atrial/VT ablation0 (0.0)1 (100.0)0.320BrS: Brugada syndrome, ICD: implantable cardioverter defibrillator, ILR: implantable …